Martin Dober
@martindober.bsky.social
Digital health and innovation expert, swiss national, global citizen, lakesai.vitafluence.com your medical research agent, Advocate for AI and compassion / iZola.life Vitafluence.ai empathicAI.life accompaniedhealth.com
Excellent news for Swiss research and entrepreneurs. It amplifies opportunities for collaboration, funding and innovation across borders.
November 10, 2025 at 4:41 PM
Excellent news for Swiss research and entrepreneurs. It amplifies opportunities for collaboration, funding and innovation across borders.
Reposted by Martin Dober
For the first time, a new ultrasound technique allows researchers to stimulate multiple locations in the brain simultaneously. This opens up new possibilities for treating devastating brain diseases such as Alzheimer’s, Parkinson’s and depression in the future.
ethz.ch/en/news-and-...
ethz.ch/en/news-and-...
Researchers use ultrasound holograms to influence brain networks
For the first time, a new ultrasound technique allows researchers to stimulate multiple locations in the brain simultaneously. This opens up new possibilities for treating devastating brain diseases s...
ethz.ch
October 3, 2025 at 6:03 AM
For the first time, a new ultrasound technique allows researchers to stimulate multiple locations in the brain simultaneously. This opens up new possibilities for treating devastating brain diseases such as Alzheimer’s, Parkinson’s and depression in the future.
ethz.ch/en/news-and-...
ethz.ch/en/news-and-...
.. wollte schon immer mal wissen, wie man Berner Rösti macht.
September 17, 2025 at 6:41 PM
.. wollte schon immer mal wissen, wie man Berner Rösti macht.
IMO the bottleneck isn’t tech. It’s willingness to adopt, especially in healthcare. The capabilities are there but trust, regulation, and mindset are lagging. I’d say the next breakthroughs will hinge more on how ready we are to rethink medicine than on the tech itself.
September 13, 2025 at 7:21 AM
IMO the bottleneck isn’t tech. It’s willingness to adopt, especially in healthcare. The capabilities are there but trust, regulation, and mindset are lagging. I’d say the next breakthroughs will hinge more on how ready we are to rethink medicine than on the tech itself.
AI is already accelerating translational research by boosting speed and precision, with emerging breakthroughs in novel therapeutic pathways.
One of the first was BenevolentAI’s rapid identification of baricitinib for COVID-19 treatment. See: pubmed.ncbi.nlm.nih.gov/35746559/
One of the first was BenevolentAI’s rapid identification of baricitinib for COVID-19 treatment. See: pubmed.ncbi.nlm.nih.gov/35746559/
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19 - PubMed
During the current pandemic, the vast majority of COVID-19 patients experienced mild symptoms, but some had a potentially fatal aberrant hyperinflammatory immune reaction characterized by high levels ...
pubmed.ncbi.nlm.nih.gov
September 12, 2025 at 5:55 PM
AI is already accelerating translational research by boosting speed and precision, with emerging breakthroughs in novel therapeutic pathways.
One of the first was BenevolentAI’s rapid identification of baricitinib for COVID-19 treatment. See: pubmed.ncbi.nlm.nih.gov/35746559/
One of the first was BenevolentAI’s rapid identification of baricitinib for COVID-19 treatment. See: pubmed.ncbi.nlm.nih.gov/35746559/
Trump, kennt sich aus mit ICE
August 14, 2025 at 7:11 PM
Trump, kennt sich aus mit ICE